Skip to content

CeriBell, Inc. CBLL Free cash flow yield

Free cash flow yield at other companies

IAR
Integra LifeSciencesIART
2.6%-2.1pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-9.9%-22.8pp
iRadimed logo
iRadimedIRMD
2%-0.2pp
Teladoc Health logo
Teladoc HealthTDOC
28.8%+8.0pp
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
-8.3%
Cerence Inc. logo
Cerence Inc.CRNC
26.4%+15.4pp

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

Based on trailing twelve months.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s free cash flow yield?
CeriBell, Inc. (CBLL) reported free cash flow yield of -7.2% in Q1 2026.
How has CeriBell, Inc.'s free cash flow yield changed year-over-year?
CeriBell, Inc.'s free cash flow yield decreased by 29.0% year-over-year, from -5.6% to -7.2%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.